Semax on TikTok: separating nootropic hype from actual data

What did @bigonial_ actually say?

The creator ran a three-week self-experiment with Semax, a synthetic peptide derived from ACTH. They started at 250 mcg daily, moved to 500 mcg, then 1 mg. Their reported effects were modest: some improved focus and a longer attention span after the dose increase, though they admitted the first two weeks felt like "mostly probably placebo." They compared Semax to Adderall "without the stimulant side effects" and described it as something that "increases BDNF" and supports neuron survival. They also offered to DM a source to anyone who asked, which is a significant detail we will come back to.

To their credit, they were refreshingly honest about the underwhelming early experience and framed the effect as a "smooth background noise enhancer" rather than a dramatic intervention. That kind of measured self-reporting is actually less common than it should be in peptide content.

Does the science back this up?

Partially, but the evidence is much thinner and more geographically narrow than this video implies. Most of what we know about Semax comes from Russian clinical research, which carries real methodological limitations and hasn't been independently replicated at scale in Western trials.

Semax (MEHFPGP) was developed at the Institute of Molecular Genetics in Moscow and has been studied primarily for stroke recovery and cognitive impairment, not healthy optimization. The BDNF claim has some basis: Dolotov et al. (2006, Journal of Neurochemistry) showed Semax increased BDNF and NGF expression in rat brain tissue. That is a real finding. But rat models of brain injury are not the same as a healthy person trying to get more done on a Tuesday morning. The leap from "increases BDNF in injured rat brains" to "improves your focus at work" is not a small one. Human RCT data in healthy adults is essentially nonexistent in peer-reviewed Western literature.

What did they get wrong (or right)?

The Adderall comparison is the part that deserves pushback. Saying Semax is "like Adderall but without the stimulant side effects" is the kind of line that sounds cool but means almost nothing scientifically. Adderall is a Schedule II amphetamine with a well-characterized mechanism involving dopamine and norepinephrine reuptake inhibition. Semax is a heptapeptide with a completely different mechanism. Comparing them is like saying a bicycle is "like a motorcycle but quieter." The framing suggests equivalent cognitive benefit with none of the downsides, and there is no human data to support that.

What they got right: the acknowledgment of likely placebo in weeks one and two is genuinely honest. The description of effects as subtle rather than dramatic also tracks with what limited human anecdote and the small clinical literature suggest. Semax is not a stimulant in the classical sense, and the creator did not oversell it as one. The dosing progression they described, 250 to 500 mcg to 1 mg, is consistent with ranges discussed in the Russian literature, though the creator should not be taken as a dosing authority here.

What should you actually know?

Semax is not approved by the FDA for any indication. It is not a legally marketed drug in the United States. The creator offering to DM a "source" for Semax is a meaningful red flag. Peptides sold outside of a licensed pharmacy and prescriber relationship exist in a legal and safety gray zone with no guarantee of sterility, concentration accuracy, or freedom from contamination. That is not a minor footnote.

Beyond the sourcing issue, intranasal and injectable Semax both require sterile technique and proper handling. Self-injection of research-grade peptides purchased through social media DMs carries real infection risk. The broader peptide optimization community often treats these compounds as low-stakes supplements, but injectable or intranasal peptides from unverified sources are not supplements. Anyone seriously interested in peptide therapy should be working through a licensed telehealth provider that can verify compound quality, not sliding into a TikTok creator's DMs.

The cognitive effects the creator reported, better focus, longer attention span after three weeks, are plausible as subjective experience. They are not proof of mechanism, and they are not a basis for recommending others try the same protocol.